Autonomic nervous system abnormalities predict cardiovascular changes after initiation of siponimod in secondary progressive multiple sclerosis-Reference-Cited by-同舟云学术

Autonomic nervous system abnormalities predict cardiovascular changes after initiation of siponimod in secondary progressive multiple sclerosis

Published:2021-02 Issue:2 Volume:132 Page:581-585
ISSN:1388-2457
Container-title:Clinical Neurophysiology
language:en
Short-container-title:Clinical Neurophysiology

Author:

Habek Mario,Crnošija Luka,Junaković Anamari,Adamec Ivan^ORCID,Barun Barbara,Gabelić Tereza,Krbot Skorić Magdalena

Publisher

Elsevier BV

Subject

Physiology (medical),Neurology (clinical),Neurology,Sensory Systems

Reference30 articles.

1. Progressive multiple sclerosis patients have a higher burden of autonomic dysfunction compared to relapsing remitting phenotype;Adamec;Clin Neurophysiol,2018

2. An update on the biology of sphingosine 1-phosphate receptors;Blaho;J Lipid Res,2014

3. Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial;Calabresi;Lancet Neurol,2014

4. Cardiac and vascular effects of fingolimod: mechanistic basis and clinical implications;Camm;Am Heart J,2014

5. Decreased maximal heart rate with aging is related to reduced {beta}-adrenergic responsiveness but is largely explained by a reduction in intrinsic heart rate;Christou;J Appl Physiol,1985

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How to explore and explain autonomic changes in multiple sclerosis;Neurophysiologie Clinique;2023-04

2. Short- and long-term effects of siponimod on autonomic nervous system in secondary progressive multiple sclerosis;Multiple Sclerosis and Related Disorders;2022-08

3. Blood pressure variability is altered in secondary progressive multiple sclerosis but not in patients with a clinically isolated syndrome;Neurophysiologie Clinique;2022-08

4. S1P receptor modulators and the cardiovascular autonomic nervous system in multiple sclerosis: a narrative review;Therapeutic Advances in Neurological Disorders;2022-01

5. Sphingosine-1-phosphate and Sphingosine-1-phosphate receptors in the cardiovascular system: pharmacology and clinical implications;Advances in Pharmacology;2022